NDRA (ENDRA Life Sciences Inc.) Quarterly EPS earnings growth

endrainc.com - graphic logo of issuer NDRA

The quarterly EPS evolution metric demonstrates the profit dynamics of ENDRA Life Sciences (NDRA), where the parameter value equals 106.60. The company's revenues are based on the implementation of TAEUS systems for affordable liver fat analysis. However, competition with ultrasound software manufacturers creates certain risks. At the same time, the brand's high reputation among radiologists supports optimism regarding the clinical potential of this technology.

endrainc.com (NDRA) Year-over-year earnings per one share growth for the last 12 months: for the period 07/04/2022 - 11/16/2026

Comprehensive metric breakdowns and analytics for ENDRA Life Sciences (NDRA)

- share price and consensus valuation forecast:
- business market valuation indicators:
Summary company analysis:ENDRA Life Sciences
Manufactured product of ENDRA Corp

Institutional investors assess the attractiveness of ENDRA Life Sciences (NDRA) through net income dynamics, where stable cash flows confirm the efficiency of diversified medical equipment supply chains. By analyzing the quarterly EPS growth rate, which measures the rate of change in earnings per share relative to the previous period, one can identify the actual profitability of the business and eliminate the risk of manipulation via one-time write-offs.